摘要
目的了解治疗心房颤动(AF)的用药现状,为选择给药方案提供依据。方法抽取门诊30例AF患者口服药物的处方,从处方诊断及用药来分析其用药趋势。结果 30例AF患者的处方中β受体阻滞剂:美托洛尔、比索洛尔;口服洋地黄类地高辛;Ⅲ类抗心律失常药胺碘酮;抗凝药小剂量阿司匹林、氢氯吡格雷片;中成药稳心颗粒为临床常用药。结论我院对AF的口服药物治疗符合我国目前临床治疗常规。无禁忌证AF者以β受体阻滞剂为首选,伴有心力衰竭者以洋地黄类为主,新出现AF或伴有哮喘、心率快而无心力衰竭者选用胺碘酮治疗;抗凝药以阿司匹林肠溶片为首选。
Objective To investigate the pharmacy status of heart atrium fibrillation （AF） medication, and to provide guidance for dosing regimen. Methods 30 prescriptions in our clinic from December 1 st to 31 st 2011 were extracted. And the pharmacy tendency was analyzed through diagnosis and prescription. Re- sults 13 receptor blocking agent used in 30 AF patients include： metoprolol, bisoprolol; oral digoxin;class Ⅲ anti-arrhythmie drug amiodarone ; anticoagulant low-dose aspirin, hydrogen clopidogrel tablets ; proprietary Chinese medicines Wenxinkeli is commonly used in clinical medicine. Conclusion The medication for AF patients in our hospital are in line with our current clinical treatment practices. 13 receptor blocking agents are the primary choice for AF patients without eontraindications; digitalis medicine is the major choice for the patients with congestive heart failure; while amiodarone is for patients with AF or accompanied by asthma and fast heartbeat without congestive heart failure; and Aspirin ECT is the primary choice as anticoagulant drug.
出处
《医学综述》
2012年第19期3315-3316,共2页
Medical Recapitulate
关键词
心房颤动
美托洛尔
地高辛
阿司匹林肠溶片
用药现状
Atrium fibrillation
Metoprolol
Digoxin
Aspirin ECT
Current medication situation
